Skip to main content

Syncona

data as at: 13/07/2020
ObjectiveTo deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.
Management groupSyncona Investment Managers
AIC sectorBiotechnology & Healthcare

Please note, some investment companies release their Net Asset Values (NAVs) less frequently than daily. For example they may provide NAVs on a weekly, monthly, quarterly or even semi-annual basis. This means that the estimated NAV shown below, and the associated discount/premium to market price, will not necessarily reflect recent market movements.

Total assets (m)Price (last close)Price (bid)Price (offer)NAVDiscount/
premium (%)
Gearing (%)Dividend yield (%)
1,236.1269.50269.50270.00186.0044.900.9

This company is not currently a member of the AIC.  We are therefore unable to provide full company information at this time.

Data provided by Morningstar.